Gartner, Inc. Interest Expense Nonoperating
Gartner, Inc. (IT) reported Interest Expense Nonoperating of $22.27 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-04
- Gartner, Inc. interest expense nonoperating for the quarter ending 2026-06-30 was $22.27M, a 88.68% increase year-over-year.
- Gartner, Inc. interest expense nonoperating for the quarter ending 2026-03-31 was $21.05M, a 56.92% increase year-over-year.
- Gartner, Inc. interest expense nonoperating for the quarter ending 2025-12-31 was $83.78M, a 13.41% increase year-over-year.
- Gartner, Inc. interest expense nonoperating for the quarter ending 2025-09-30 was $16.28M, a 9.36% decline year-over-year.
- Gartner, Inc. interest expense nonoperating for fiscal 2025 was $125.28M, a 4.40% decline from fiscal 2024.
- Gartner, Inc. interest expense nonoperating for fiscal 2024 was $131.05M, a 1.30% decline from fiscal 2023.
- Gartner, Inc. interest expense nonoperating for fiscal 2023 was $132.77M, a 5.21% increase from fiscal 2022.
- Gartner, Inc. interest expense nonoperating for fiscal 2022 was $126.20M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $22.27M 10-Q · filed 2026-08-04 | $43.31M 10-Q · filed 2026-08-04 | $127.10M derived: sum of 3 quarters · filed 2026-08-04 | $143.38M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $21.05M 10-Q · filed 2026-05-05 | $104.83M derived: sum of 2 quarters · filed 2026-05-05 | $121.11M derived: sum of 3 quarters · filed 2026-05-05 | $132.91M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $83.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $100.06M derived: sum of 2 quarters · filed 2026-02-12 | $111.86M derived: sum of 3 quarters · filed 2026-08-04 | $125.28M 10-K · filed 2026-02-12 |
| 2025-09-30 | $16.28M 10-Q · filed 2025-11-04 | $28.08M derived: sum of 2 quarters · filed 2026-08-04 | $41.49M 10-Q · filed 2025-11-04 | $115.37M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $11.80M 10-Q · filed 2026-08-04 | $25.21M 10-Q · filed 2026-08-04 | $99.09M derived: sum of 3 quarters · filed 2026-08-04 | $117.05M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $13.41M 10-Q · filed 2026-05-05 | $87.29M derived: sum of 2 quarters · filed 2026-05-05 | $105.25M derived: sum of 3 quarters · filed 2026-05-05 | $125.24M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $73.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $91.84M derived: sum of 2 quarters · filed 2026-02-12 | $111.83M derived: sum of 3 quarters · filed 2026-02-12 | $131.05M 10-K · filed 2026-02-12 |
| 2024-09-30 | $17.96M 10-Q · filed 2025-11-04 | $37.95M derived: sum of 2 quarters · filed 2025-11-04 | $57.17M 10-Q · filed 2025-11-04 | $116.17M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-06-30 | $19.99M 10-Q · filed 2025-08-05 | $39.21M 10-Q · filed 2025-08-05 | $98.21M derived: sum of 3 quarters · filed 2026-02-12 | $120.03M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-03-31 | $19.22M 10-Q · filed 2025-05-06 | $78.22M derived: sum of 2 quarters · filed 2026-02-12 | $100.04M derived: sum of 3 quarters · filed 2026-02-12 | $124.60M derived: sum of 4 quarters · filed 2026-02-12 |
| 2023-12-31 | $59.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $80.82M derived: sum of 2 quarters · filed 2026-02-12 | $105.38M derived: sum of 3 quarters · filed 2026-02-12 | $132.77M 10-K · filed 2026-02-12 |
| 2023-09-30 | $21.82M 10-Q · filed 2024-11-05 | $46.38M derived: sum of 2 quarters · filed 2024-11-05 | $73.77M 10-Q · filed 2024-11-05 | |
| 2023-06-30 | $24.56M 10-Q · filed 2024-07-30 | $51.95M 10-Q · filed 2024-07-30 | ||
| 2022-12-31 | $126.20M 10-K · filed 2025-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evolent Health, Inc. (EVH) | United States | $0.397B | -1.21 |
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |